Please assess the completion status of the following clinical trial:

Trial Title: RFA RCT for Pancreatic or Bile Duct Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~- Either gender greater than or equal to 18 years of age.~* Pancreatic cancer or cholangiocarcinoma unsuitable for surgical resection. Criteria of unresectability being based on 1) metastatic disease or 2) locally advanced. Subjects that are deemed to be unresectable will be determined by a surgeon or treating oncologist.~* Biliary obstruction~* Subjects capable of giving informed consent~* Life expectancy of at least 6 months~Exclusion Criteria:~- Exclusion Criteria~* Cardiac Pacemaker~* Patient unstable for ERCP or has failed ERCP (endoscopic retrograde cholangiopancreatography )~* Inability to give informed consent~* Uncorrected coagulopathy~* Pregnant

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Radiofrequency Ablation (EndoHbp probe) (Type: EXPERIMENTAL): Radiofrequency Ablation using EndoHPB Probe
- Stenting only (Type: ACTIVE_COMPARATOR): Stenting only

Based on this trial design, predict the completion outcome and termination type (if applicable).